Videos & Visuals

Amyloid neuropathies

Amyloidosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

Deadly genetic disease often misdiagnosed among Black patients

Cardiomyopathy & Amyloidosis

Role of Graphene Oxide in Disentangling Amyloid Beta Fibrils

Cardiac Amyloidosis

ASG - ATTR Webinar 03-09-2024

Chapters:0:00 Welcome and Speaker Introductions3:09 ATTR Treatment Chart3:30 Dr. Tony Urey, Current FDA Approved Treatments for ATTR Amyloidosis21:31 Dr. Chafic…

Prothena - Advancing AL Amyloidosis Treatment

Patients with AL amyloidosis can present with a wide range of general symptoms that are common to other conditions such as fatigue, shortness of breath or edema.…

Subscribe to

Newsletter

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.